ID

35467

Beskrivning

Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02376452

Länk

https://clinicaltrials.gov/show/NCT02376452

Nyckelord

Versioner (1)
  1. 2019-03-05 2019-03-05 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

5 mars 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Colorectal Carcinoma NCT02376452

Engelsk

Eligibility Colorectal Carcinoma NCT02376452

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
aged 18-70 years with histologically or cytologically confirmed advanced colorectal adenocarcinoma
Beskrivning

Age | Adenocarcinoma of large intestine Advanced

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C1319315
UMLS CUI [2,2]
C0205179
eastern cooperative oncology group performance status of 0 to 1
Beskrivning

ECOG performance status

Datatyp

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy of ≥ 3 months
Beskrivning

Life Expectancy

Datatyp

boolean

Alias
UMLS CUI [1]
C0023671
patients who had failed first-line treatment with either xelox (capecitabine combined with oxaliplatin) or folfox (5-fluorouracil/leucovorin with oxaliplatin)
Beskrivning

First line treatment failed | Xeloda-Oxaliplatin Regimen | FOLFOX Regimen

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1708063
UMLS CUI [1,2]
C0231175
UMLS CUI [2]
C1956962
UMLS CUI [3]
C0392943
at least one measurable disease lesion according to the response evaluation criteria in solid tumors (recist 1.1) criteria
Beskrivning

Measurable lesion Quantity

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
have adequate bone marrow, hepatic, and renal function
Beskrivning

Bone Marrow function | Liver function | Renal function

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with previous chronic inflammatory bowel disease, chronic diarrhea or recurrent bowel obstruction
Beskrivning

Chronic inflammatory bowel disease | Chronic diarrhea | Intestinal Obstruction Recurrent

Datatyp

boolean

Alias
UMLS CUI [1]
C1856359
UMLS CUI [2]
C0401151
UMLS CUI [3,1]
C0021843
UMLS CUI [3,2]
C2945760
patients with symptomatic brain metastases
Beskrivning

Metastatic malignant neoplasm to brain Symptomatic

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C0231220
active clinical severe infection
Beskrivning

Communicable Disease Severe

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205082
previously received irinotecan or raltitrexed
Beskrivning

irinotecan | raltitrexed

Datatyp

boolean

Alias
UMLS CUI [1]
C0123931
UMLS CUI [2]
C0677667
dihydropyrimidine dehydrogenase (dpd) enzyme adequate
Beskrivning

Dihydropyrimidine dehydrogenase Adequate

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0058126
UMLS CUI [1,2]
C0205411
Tillbaka till toppen

Similar models

Eligibility Colorectal Carcinoma NCT02376452

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Age | Adenocarcinoma of large intestine Advanced
Item
aged 18-70 years with histologically or cytologically confirmed advanced colorectal adenocarcinoma
boolean
C0001779 (UMLS CUI [1])
C1319315 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
ECOG performance status
Item
eastern cooperative oncology group performance status of 0 to 1
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy of ≥ 3 months
boolean
C0023671 (UMLS CUI [1])
First line treatment failed | Xeloda-Oxaliplatin Regimen | FOLFOX Regimen
Item
patients who had failed first-line treatment with either xelox (capecitabine combined with oxaliplatin) or folfox (5-fluorouracil/leucovorin with oxaliplatin)
boolean
C1708063 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
C1956962 (UMLS CUI [2])
C0392943 (UMLS CUI [3])
Measurable lesion Quantity
Item
at least one measurable disease lesion according to the response evaluation criteria in solid tumors (recist 1.1) criteria
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Bone Marrow function | Liver function | Renal function
Item
have adequate bone marrow, hepatic, and renal function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Chronic inflammatory bowel disease | Chronic diarrhea | Intestinal Obstruction Recurrent
Item
patients with previous chronic inflammatory bowel disease, chronic diarrhea or recurrent bowel obstruction
boolean
C1856359 (UMLS CUI [1])
C0401151 (UMLS CUI [2])
C0021843 (UMLS CUI [3,1])
C2945760 (UMLS CUI [3,2])
Metastatic malignant neoplasm to brain Symptomatic
Item
patients with symptomatic brain metastases
boolean
C0220650 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
Communicable Disease Severe
Item
active clinical severe infection
boolean
C0009450 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
irinotecan | raltitrexed
Item
previously received irinotecan or raltitrexed
boolean
C0123931 (UMLS CUI [1])
C0677667 (UMLS CUI [2])
Dihydropyrimidine dehydrogenase Adequate
Item
dihydropyrimidine dehydrogenase (dpd) enzyme adequate
boolean
C0058126 (UMLS CUI [1,1])
C0205411 (UMLS CUI [1,2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial